Chemotherapy‐induced peripheral neurotoxicity: a critical analysis SB Park, D Goldstein, AV Krishnan, CSY Lin, ML Friedlander, J Cassidy, ...
CA: a cancer journal for clinicians 63 (6), 419-437, 2013
788 2013 Bell's palsy: aetiology, clinical features and multidisciplinary care TJ Eviston, GR Croxson, PGE Kennedy, T Hadlock, AV Krishnan
Journal of Neurology, Neurosurgery & Psychiatry 86 (12), 1356-1361, 2015
456 2015 Riluzole, neuroprotection and amyotrophic lateral sclerosis BC Cheah, S Vucic, AV Krishnan, MC Kiernan
Current medicinal chemistry 17 (18), 1942-1959, 2010
324 2010 Uremic neuropathy: clinical features and new pathophysiological insights AV Krishnan, MC Kiernan
Muscle & Nerve: Official Journal of the American Association of …, 2007
283 2007 Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies SB Park, AV Krishnan, C Lin, D Goldstein, M Friedlander, MC Kiernan
Current medicinal chemistry 15 (29), 3081-3094, 2008
270 2008 Oxaliplatin‐induced neurotoxicity and the development of neuropathy AV Krishnan, D Goldstein, M Friedlander, MC Kiernan
Muscle & Nerve: Official Journal of the American Association of …, 2005
266 2005 Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy SB Park, CSY Lin, AV Krishnan, D Goldstein, ML Friedlander, MC Kiernan
Brain 132 (10), 2712-2723, 2009
251 2009 Neurological complications in chronic kidney disease R Arnold, T Issar, AV Krishnan, BA Pussell
JRSM cardiovascular disease 5, 2048004016677687, 2016
228 2016 Long‐term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility SB Park, CSY Lin, AV Krishnan, D Goldstein, ML Friedlander, MC Kiernan
The oncologist 16 (5), 708-716, 2011
225 2011 Neurological complications of chronic kidney disease AV Krishnan, MC Kiernan
Nature Reviews Neurology 5 (10), 542-551, 2009
214 2009 Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity SB Park, D Goldstein, CSY Lin, AV Krishnan, ML Friedlander, MC Kiernan
Journal of clinical Oncology 27 (8), 1243-1249, 2009
214 2009 Axonal ion channels from bench to bedside: a translational neuroscience perspective AV Krishnan, CSY Lin, SB Park, MC Kiernan
Progress in neurobiology 89 (3), 288-313, 2009
193 2009 Altered motor nerve excitability in end-stage kidney disease AV Krishnan, RKS Phoon, BA Pussell, JA Charlesworth, H Bostock, ...
Brain 128 (9), 2164-2174, 2005
181 2005 Altered nerve excitability properties in established diabetic neuropathy AV Krishnan, MC Kiernan
Brain 128 (5), 1178-1187, 2005
170 2005 Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis S Vucic, CSY Lin, BC Cheah, J Murray, P Menon, AV Krishnan, ...
Brain 136 (5), 1361-1370, 2013
153 2013 Differentiating lower motor neuron syndromes N Garg, SB Park, S Vucic, C Yiannikas, J Spies, J Howells, W Huynh, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (6), 474-483, 2017
131 2017 Effect of oxygen stoichiometry on the electrical properties of electrodes S Madhukar, S Aggarwal, AM Dhote, R Ramesh, A Krishnan, D Keeble, ...
Journal of applied physics 81 (8), 3543-3547, 1997
128 1997 Activity-dependent excitability changes suggest Na+ /K+ pump dysfunction in diabetic neuropathy AV Krishnan, CSY Lin, MC Kiernan
Brain 131 (5), 1209-1216, 2008
113 2008 Oxaliplatin and axonal Na+ channel function in vivo AV Krishnan, D Goldstein, M Friedlander, MC Kiernan
Clinical cancer research 12 (15), 4481-4484, 2006
106 2006 Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity SB Park, CSY Lin, AV Krishnan, D Goldstein, ML Friedlander, MC Kiernan
PloS one 6 (4), e18469, 2011
104 2011